Task One:
Over the next five years advertisement and marketing of big companies involving possible vaccines for cervical cancer will begin to appear. The stress of making sure that this vaccine is administarted and other possible cures detected will increase dramaticaly. Research on this product will continue to grow and bring new possibilities and ideas for the future cervical patients. The growth of this product will bring recognition to research and experimentation of compaines, which will help bring more funding and demand for this product and for new possible better products to come.
Task Two:
Digene Corp. supports the Academy for Educational Development (AED) and the Coalition of Labor Union Women (CLUW), which are working together to launch a campaign to reduce cervical cancer rates among the more than 16 million women in union families across the United States
Working Women Reaching Out against Cervical Cancer (Working Women ROCC!) a five-year joined program between AED and CLUW, which is funded by a grant from the Centers for Disease Control and Prevention (CDC). Studies show that cervical cancer, a preventable disease, disproportionately affects minority women, which make up a large proportion of female union members. Working Women ROCC! will tcommend AED and CLUW for undertaking this effort to educate women about HPV and cervical cancer, and opportunities to prevent cervical cancer through regular and accurate screening. Working Wemon ROCC! believes that working women should have access to the best preventive health technologies. As HPV testing begins to turn into a standard of practice for cervical cancer screening in women age 30 and older, it is important that all eligible women have access to the technology and are properly educated about how to prevent cervical cancer
http://www.cpaaindia.org/infocentre/clipping_cc.htm#Digene31082004
http://www.digene.com/inforeq@digene.com
http://www.goldmood.com/cosmos/h/DIGE.html
Task 3:
Our biggest task is to try to create an easier way to administer the cervical cancer vaccine so that people all over the world are able to acquire this vaccine. First, we plan to lower the cost of the vaccine. Also, we plan to decrease the dosage, so that each patient gets the same amount of nutrients, only packed into a smaller amount of the vaccine, which also lowers the cost. Lastly, this vaccine will be easier to administer around the world because it will be cheaper, so third-world countries will be able to easily afford the vaccine, and smaller dosages would make it easier to transport.